Metabolic dysfunction-associated steatotic liver disease in Cushing's syndrome: prevalence, determinants, and changes after remission.

Front Endocrinol (Lausanne) · 2026 · PMC13152751 · PMID 42109743

Europe PMC DOI

hedged sentences

0.0590

closest p · 1.2× alpha

0.0780

boldest claim

The sentences

did not reach statistical significancep=0.059so close (0.05 < p ≤ 0.1)

Age tended to be lower in MASLD (+) patients in adrenal CS (52 [42–59] vs 55 [46.5–66] years), although this did not reach statistical significance (p=0.059), and no significant age difference was observed in pituitary CS (p=0.141).

also in 77,393 other papers

a trend toward significancep = 0.078so close (0.05 < p ≤ 0.1)

showed a trendp = 0.078so close (0.05 < p ≤ 0.1)

The duration of symptoms before diagnosis showed a trend toward significance (OR 1.04, 95% CI 0.99–1.08; p = 0.078).

also in 2,745 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.